Purchase Order 75N91024P00531
Award Date 9/1/24
Potential Completion Date 10/31/24
Potential Value $38K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
- This is a federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH). The $129,500.00 firm fixed-price delivery order was issued under the General Services Administration (GSA) Federal Supply Schedule contract GS24F2044D. The contract does not have a set-aside designation. The award supports the provision of specialized equipment, reagents, and services by BD...
- This is a firm-fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $5,509.79. The delivery order is for flow cytometric analysis of benign and malignant tumors. BD is a global medical technology company that provides a wide range of products and services to government agencies, including instrumentation, reagents, and services for biomedical research and clinical applications....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $12,821.67 to Becton, Dickinson And Company (BD) for the acquisition of a 5-laser SORP cell analyzer instrument. This instrument is currently being used by all members of the EIB (likely referring to an internal NIH program) to prevent disruption of ongoing research experiments. The contract has a completion date of July 1, 2024. BD is a...
- This federal contract award from the National Cancer Institute (NCI) to Becton, Dickinson And Company (BD) is for the procurement of a BD BIOSCIENCES - LSR II LASER and LSR/FORTESSA Z230SFF WORKSTATION BUNDLE SYSTEM. The $86,150.00 firm fixed-price purchase order has an ultimate completion date of August 5, 2015. The contract was awarded on May 6, 2015 and does not have a set-aside designation. BD Biosciences, a division of BD, is a major supplier of specialized biomedical research equipment and...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,809.08 firm fixed price purchase order to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a service agreement. As the prime contractor, Becton, Dickinson and Company BD Biosciences will provide unspecified services to the National Cancer Institute, which conducts and supports research across the nation with the goal of discovering prevention and...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The $698,027.48 firm fixed price purchase order was awarded on August 29, 2018 to provide a BD Biosciences FACSymphony, or equal, fluorescent analytical flow cytometer. This equipment is being procured to support the National Cancer Institute's research programs. The...
- This federal contract award, HHSN261201500300P, was made by the National Cancer Institute, a civilian agency within the U.S. government, to Becton, Dickinson and Company (BD), a global medical technology company. The contract, valued at $111,065.00, is for the purchase and installation of a BD LSRII Special Order Laser Option. This award was not set aside for any specific business designation. The contract is a firm fixed-price purchase order. BD Biosciences, a division of BD, has extensive...
- This federal contract award, issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), is a Blanket Purchase Agreement (BPA) Call with Becton, Dickinson and Company (BD) for $15,700. The contract is for the delivery of specialized biomedical products and services to support NCI's research programs. BD, a global medical technology company, will provide instruments, reagents, and technical expertise for flow cytometry, cell imaging, and genomics...